Literature DB >> 29769847

Outbreak of measles in a non-immunizing population, Alberta 2013.

T Kershaw1, V Suttorp2, K Simmonds3, T St Jean3.   

Abstract

BACKGROUND: An outbreak of measles was declared in southern Alberta on October 18, 2013, after a case had been reported to the local public health unit in a non-immunized teenager with recent travel to the Netherlands. The teenager had had contact with a large number of unimmunized people while infectious; therefore, the risk of spread was high. The potential for an outbreak of measles in this area had been identified by the lead Medical Officer of Health for South Zone, and planning for an outbreak had begun in August 2013.
METHODS: Several public health measures were implemented to control the outbreak: mass immunization clinics; an outbreak dose of measles mumps and rubella (MMR) vaccine for infants 6-12 months old; communication within the affected and surrounding communities; a dedicated measles hotline; a Mobile Measles Assessment Team; and a Measles Assessment Centre.
RESULTS: A total of 42 confirmed cases were identified during the outbreak between October 16 and November 25. Just over half the cases were male (52.4%). The average age was 12 (range < 1 to 24 years) and the median age 13 years. There was one hospitalization, and no deaths occurred. All cases were unimmunized. Cases were located in five communities immediately surrounding Lethbridge. All but two cases were epidemiologically linked within 10 households.
CONCLUSION: The planning that occurred before the outbreak was essential in containing the outbreak to 10 households. To prevent future outbreaks of measles, exploring strategies for increasing immunization coverage rates in unimmunized populations is essential. When immunization acceptance is not uniform, other public health strategies should be planned for and implemented in order to prevent additional spread.

Entities:  

Year:  2014        PMID: 29769847      PMCID: PMC5864473          DOI: 10.14745/ccdr.v40i12a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  5 in total

1.  Teaching mothers about childhood immunizations.

Authors:  D B Evers
Journal:  MCN Am J Matern Child Nurs       Date:  2001 Sep-Oct       Impact factor: 1.412

2.  Childhood immunizations: a parent education and incentive program.

Authors:  Marilyn Therese Lieber; Faith Yvonne C Colden; Ana Lizzette Colón
Journal:  J Pediatr Health Care       Date:  2003 Sep-Oct       Impact factor: 1.812

Review 3.  Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination.

Authors:  Edward Mills; Alejandro R Jadad; Cory Ross; Kumanan Wilson
Journal:  J Clin Epidemiol       Date:  2005-11       Impact factor: 6.437

4.  Large ongoing measles outbreak in a religious community in the Netherlands since May 2013.

Authors:  Mj Knol; At Urbanus; Em Swart; L Mollema; Wl Ruijs; Rs van Binnendijk; Mj Te Wierik; He de Melker; A Timen; Sj Hahne
Journal:  Euro Surveill       Date:  2013-09-05

Review 5.  Barriers to immunization and missed opportunities.

Authors:  J M Santoli; P G Szilagyi; L E Rodewald
Journal:  Pediatr Ann       Date:  1998-06       Impact factor: 1.132

  5 in total
  10 in total

1.  The challenges of sustaining measles elimination in Canada.

Authors:  N S Crowcroft
Journal:  Can Commun Dis Rep       Date:  2014-06-12

2.  Outbreak reporting guide.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2015-04-02

3.  A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax).

Authors:  Noni E MacDonald; Eve Dubé
Journal:  Can Commun Dis Rep       Date:  2020-01-02

4.  An equity-based assessment of immunization-related responses in urban Alberta during the 2014 measles outbreak: a comparative analysis between Calgary and Edmonton.

Authors:  Thilina Bandara; Cory Neudorf; Nazeem Muhajarine
Journal:  Can J Public Health       Date:  2022-01-13

5.  Measles surveillance in Canada: Trends for 2013.

Authors:  A Shane; J Hiebert; L Sherrard; H Deehan
Journal:  Can Commun Dis Rep       Date:  2014-06-12

6.  Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology.

Authors:  Tom Woudenberg; Rob S van Binnendijk; Elisabeth A M Sanders; Jacco Wallinga; Hester E de Melker; Wilhelmina L M Ruijs; Susan J M Hahné
Journal:  Euro Surveill       Date:  2017-01-19

7.  Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015.

Authors:  Lauren C Ramsay; Natasha S Crowcroft; Shari Thomas; Elena Aruffo; Alexandra Teslya; Jane M Heffernan; Effie Gournis; Joanne Hiebert; Valerie Jaeger; Manisa Jiaravuthisan; Jennifer Sharron; Alberto Severini; Shelley L Deeks; Jonathan Gubbay; Tony Mazzulli; Beate Sander
Journal:  Euro Surveill       Date:  2019-03

8.  Impact of the COVID-19 pandemic on vaccine coverage for early childhood vaccines in Alberta, Canada: a population-based retrospective cohort study.

Authors:  Shannon E MacDonald; Yuba Raj Paudel; Marilou Kiely; Ellen Rafferty; Manish Sadarangani; Joan L Robinson; S Michelle Driedger; Lawrence W Svenson
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

9.  Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.

Authors:  Selma Osman; Natasha Crowcroft; Elizabeth McLachlan; Todd Hatchette; Carol Perez-Iratxeta; Eugene Joh; James Wright; Scott A Halperin; Shelley Deeks; Sarah Wilson; Sarah Buchan; Brian Ward; Jonathan Gubbay; Marc Brisson; Bouchra Serhir; Alberto Severini; Shelly Bolotin
Journal:  Vaccine       Date:  2022-04-28       Impact factor: 4.169

Review 10.  Public health responses during measles outbreaks in elimination settings: Strategies and challenges.

Authors:  Paul A Gastañaduy; Emily Banerjee; Chas DeBolt; Pamela Bravo-Alcántara; Samia A Samad; Desiree Pastor; Paul A Rota; Manisha Patel; Natasha S Crowcroft; David N Durrheim
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.